FDA Inspection
Delpharm DijonDelpharm Dijon – FDA Inspection, May 31, 2024
Record Details
This FDA Inspection record concerns Delpharm Dijon, with an inspection on May 31, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 48fc0cb0-6971-42cf-ba56-e0f08bc7a3ac
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240699
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.186(b)(7)Theoretical Yield and Percentages
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delpharm Dijon
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 19, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delpharm Dijon
- FDA Inspection 1229926 - 2021-11-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.